| Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response X Gao, Q Cao, Y Cheng, D Zhao, Z Wang, H Yang, Q Wu, L You, Y Wang, ... Proceedings of the National Academy of Sciences 115 (13), E2960-E2969, 2018 | 333 | 2018 |
| Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway Y Cheng, XH Gao, XJ Li, QH Cao, DD Zhao, JR Zhou, HX Wu, Y Wang, ... Oncogene 37 (22), 2953-2966, 2018 | 70 | 2018 |
| Depression-induced neuropeptide Y secretion promotes prostate cancer growth by recruiting myeloid cells Y Cheng, XY Tang, YX Li, DD Zhao, QH Cao, HX Wu, HB Yang, K Hao, ... Clinical Cancer Research 25 (8), 2621-2632, 2019 | 62 | 2019 |
| Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway J Mao, D Wang, Z Wang, W Tian, X Li, J Duan, Y Wang, H Yang, L You, ... Cancer Letters 380 (1), 134-143, 2016 | 50 | 2016 |
| Gαi1 and Gαi3 regulate macrophage polarization by forming a complex containing CD14 and Gab1 X Li, D Wang, Z Chen, E Lu, Z Wang, J Duan, W Tian, Y Wang, L You, ... Proceedings of the National Academy of Sciences 112 (15), 4731-4736, 2015 | 50 | 2015 |
| FOXM1 regulates glycolysis and energy production in multiple myeloma Y Cheng, F Sun, K Thornton, X Jing, J Dong, G Yun, M Pisano, F Zhan, ... Oncogene 41 (32), 3899-3911, 2022 | 29 | 2022 |
| Investigation of pharmacokinetics, tissue distribution and excretion of schisandrin B in rats by HPLC–MS/MS Z Wang, L You, Y Cheng, K Hu, Z Wang, Y Cheng, J Yang, Y Yang, ... Biomedical Chromatography 32 (2), e4069, 2018 | 29 | 2018 |
| Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related peripheral neuropathy Y Zhang, M Pisano, N Li, G Tan, F Sun, Y Cheng, Y Zhang, X Cui Cellular Signalling 78, 109872, 2021 | 18 | 2021 |
| Germline risk contribution to genomic instability in multiple myeloma S Janz, F Zhan, F Sun, Y Cheng, M Pisano, Y Yang, H Goldschmidt, ... Frontiers in genetics 10, 424, 2019 | 18 | 2019 |
| Combination of sorafenib and enzalutamide as a potential new approach for the treatment of castration-resistant prostate cancer H Wu, L Zhang, X Gao, X Zhang, J Duan, L You, Y Cheng, J Bian, Q Zhu, ... Cancer letters 385, 108-116, 2017 | 18 | 2017 |
| Autonomic nervous system control of multiple myeloma Y Cheng, F Sun, A D'Souza, B Dhakal, M Pisano, S Chhabra, M Stolley, ... Blood reviews 46, 100741, 2021 | 17 | 2021 |
| CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation D Gai, JR Chen, JP Stewart, I Nookaew, H Habelhah, C Ashby, F Sun, ... The Journal of clinical investigation 132 (18), 2022 | 14 | 2022 |
| Loss of a negative feedback loop between IRF8 and AR promotes prostate cancer growth and enzalutamide resistance H Wu, L You, Y Li, Z Zhao, G Shi, Z Chen, Z Wang, X Li, S Du, W Ye, ... Cancer research 80 (13), 2927-2939, 2020 | 14 | 2020 |
| WDR26 and MTF2 are therapeutic targets in multiple myeloma F Sun, Y Cheng, JD Riordan, A Dupuy, W Dubois, M Pisano, J Dong, ... Journal of Hematology & Oncology 14, 1-7, 2021 | 7 | 2021 |
| Bispecific CAR-T cells targeting both BCMA and CD24: a potentially treatment approach for multiple myeloma F Sun, Y Cheng, B Peng, H Xu, F van Rhee, S Janz, G Tricot, ... Blood 138, 2802, 2021 | 5 | 2021 |
| Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth F Sun, Y Cheng, V Wanchai, W Guo, D Mery, H Xu, D Gai, E Siegel, ... Nature communications 15 (1), 615, 2024 | 4 | 2024 |
| High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma Y Cheng, F Sun, DV Alapat, V Wanchai, D Mery, W Guo, H Cao, Y Zhu, ... Cell Reports Medicine 4 (10), 2023 | 4 | 2023 |
| Laboratory mice–A driving force in immunopathology and immunotherapy studies of human multiple myeloma M Pisano, Y Cheng, F Sun, B Dhakal, A D’Souza, S Chhabra, JM Knight, ... Frontiers in Immunology 12, 667054, 2021 | 4 | 2021 |
| Osteolytic disease in IL-6 and Myc dependent mouse model of human myeloma F Sun, Y Cheng, SA Walsh, MR Acevedo, X Jing, SS Han, MD Pisano, ... haematologica 105 (3), e111, 2020 | 4 | 2020 |
| A gene signature can predict risk of MGUS progressing to multiple myeloma F Sun, Y Cheng, J Ying, D Mery, S Al Hadidi, V Wanchai, ER Siegel, H Xu, ... Journal of Hematology & Oncology 16 (1), 70, 2023 | 3 | 2023 |
